GO:1904206 positive regulation of skeletal muscle hypertrophy: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904206 describes any biological process that activates or increases the frequency, rate, or extent of skeletal muscle hypertrophy, the enlargement of muscle fibers through increased protein accretion and myonuclear addition.
• Mechanical loading, amino acid availability, and anabolic hormones converge on mTORC1 signaling to drive the translational machinery required for hypertrophy.
• Satellite cells supply new myonuclei to growing fibers, and their dysfunction impairs hypertrophic adaptation in neuromuscular disorders.
• Dietary protein and resistance exercise synergistically stimulate muscle protein synthesis and net protein balance, forming the practical basis for hypertrophy interventions.
• Age-related muscle loss (sarcopenia) involves dysregulation of hypertrophic signaling, mitochondrial function, and stress-response pathways such as HSF1-SIRT3-PGC1α.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal testing of candidate genes in the positive regulation of skeletal muscle hypertrophy.
Description
Skeletal muscle hypertrophy is the enlargement of muscle fibers resulting from an increase in myofibrillar protein content and, in many contexts, the addition of new myonuclei. The Gene Ontology term GO:1904206, positive regulation of skeletal muscle hypertrophy, captures any process that activates or increases the frequency, rate, or extent of this growth response. This term is of central interest to researchers in muscle biology, exercise physiology, and metabolic disease because the same pathways that drive physiological hypertrophy are often dysregulated in sarcopenia, cachexia, and neuromuscular disorders. Understanding the positive regulators of hypertrophy therefore has direct implications for developing interventions that preserve or restore muscle mass.
positive regulation of skeletal muscle hypertrophy At A Glance
| GO ID | GO:1904206 |
|---|---|
| GO term | positive regulation of skeletal muscle hypertrophy |
| Ontology | biological_process |
| Synonym | activation of skeletal muscle hypertrophy; up regulation of skeletal muscle hypertrophy; up-regulation of skeletal muscle hypertrophy; upregulation of skeletal muscle hypertrophy |
| Major function | Activates or increases the frequency, rate, or extent of skeletal muscle hypertrophy |
| Related processes | mTORC1 signaling, protein synthesis, satellite cell activation, myonuclear accretion |
| Disease relevance | Sarcopenia, cachexia, neuromuscular disorders, metabolic disease |
| Research methods | CRISPR knockout/knock-in, Ribo-seq, RNA-seq, proteomics, imaging |
What Is GO:1904206?
GO:1904206 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of skeletal muscle hypertrophy. In practical terms, it encompasses the signaling events, transcriptional programs, and cellular behaviors that promote the enlargement of skeletal muscle fibers, including anabolic signaling, enhanced protein synthesis, satellite cell activation, and myonuclear accretion.
Why Is positive regulation of skeletal muscle hypertrophy Important in Cell Biology?
Positive regulation of skeletal muscle hypertrophy is fundamental to understanding how muscle mass is gained and maintained. The pathways that positively regulate hypertrophy are the same pathways that are impaired in age-related sarcopenia, cancer cachexia, and inherited myopathies, making this GO term a focal point for translational research. Moreover, because muscle mass is a major determinant of metabolic health and physical function, identifying the genes and mechanisms that positively regulate hypertrophy can inform exercise, nutritional, and pharmacological strategies to preserve muscle across the lifespan.
• Defines the anabolic processes that increase muscle fiber size and strength.
• Provides a framework for understanding how resistance exercise and protein intake promote muscle growth.
• Links mechanical loading to intracellular signaling and translational control.
• Highlights the role of satellite cells in supplying myonuclei for hypertrophic growth.
• Explains how dysregulation of anabolic signaling contributes to sarcopenia.
• Supports development of therapies for muscle wasting in cachexia and neuromuscular disease.
• Guides CRISPR-based functional genomics of muscle growth genes.
• Informs nutritional and exercise prescriptions for muscle health.
• Connects mitochondrial function and stress responses to muscle maintenance.
• Enables cross-species comparison of muscle aging and hypertrophy mechanisms.
What Happens During positive regulation of skeletal muscle hypertrophy?
Mechanical and Nutritional Stimuli
In simple terms: Exercise and food provide the initial signals that tell muscle to grow.
Resistance exercise and amino acid availability are the primary external stimuli that positively regulate skeletal muscle hypertrophy. Mechanical tension and protein ingestion increase muscle protein synthesis and net protein balance, creating the conditions for fiber enlargement. These stimuli are integrated by mechanosensors and nutrient-sensing pathways that initiate anabolic signaling.
mTORC1 Activation and Translational Control
In simple terms: A master switch called mTORC1 turns on protein production for muscle growth.
The mechanistic target of rapamycin complex 1 (mTORC1) is a central node in the positive regulation of skeletal muscle hypertrophy. Activation of mTORC1 by mechanical loading, amino acids, and growth factors promotes phosphorylation of downstream effectors such as p70S6K1 and 4E-BP1, enhancing translation initiation and ribosome biogenesis. This translational program supports the accumulation of myofibrillar proteins required for hypertrophy.
Satellite Cell Activation and Myonuclear Accretion
In simple terms: Stem cells in muscle donate new nuclei to growing fibers.
Satellite cells are muscle-resident stem cells that become activated in response to loading or injury, proliferate, and fuse with existing fibers to donate myonuclei. This myonuclear accretion supports the transcriptional demand of hypertrophic growth and is considered a positive regulator of skeletal muscle hypertrophy. Dysfunction of satellite cells impairs hypertrophic adaptation and contributes to neuromuscular disorders.
Transcriptional and Epigenetic Remodeling
In simple terms: The cell changes which genes are turned on to support growth.
Hypertrophic stimuli induce transcriptional programs that increase expression of myogenic regulatory factors and metabolic genes. Epigenetic modifications and transcription factor networks, including those downstream of mTORC1, coordinate the expression of genes involved in protein synthesis, mitochondrial function, and stress responses. These changes reinforce the anabolic state and support long-term muscle growth.
Mitochondrial and Stress-Response Adaptation
In simple terms: Muscle cells adjust their energy factories and stress defenses to sustain growth.
Positive regulation of hypertrophy involves coordinated adaptation of mitochondrial function and stress-response pathways. For example, HSF1 alleviates age-associated sarcopenia and mitochondrial decline via a SIRT3-PGC1α axis, linking proteostasis and mitochondrial quality control to muscle maintenance. Such adaptations help match energy supply to the increased biosynthetic demand of growing fibers.
Key Genes Involved in GO:1904206 positive regulation of skeletal muscle hypertrophy
The following genes and proteins are established or emerging players in the positive regulation of skeletal muscle hypertrophy, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Central kinase in mTORC1 anabolic signaling | Target for hypertrophy and atrophy studies |
| RPTOR | Scaffold protein of mTORC1 | Required for mTORC1-mediated translation |
| RPS6KB1 | p70S6K1 kinase downstream of mTORC1 | Marker of translational activation |
| EIF4EBP1 | 4E-BP1 repressor of translation initiation | Readout of mTORC1 activity |
| IGF1 | Anabolic growth factor | Stimulates protein synthesis and satellite cells |
| MSTN | Myostatin, negative regulator of growth | Knockout increases muscle mass |
| PAX7 | Satellite cell marker and regulator | Required for satellite cell function |
| MYOD1 | Myogenic regulatory factor | Drives myogenic differentiation |
| MYF5 | Myogenic regulatory factor | Satellite cell activation |
| MYOG | Myogenin, differentiation factor | Fusion and myotube formation |
| HSF1 | Stress-responsive transcription factor | Protects against sarcopenia via SIRT3-PGC1α |
| SIRT3 | Mitochondrial deacetylase | Mitochondrial function in aging muscle |
| PPARGC1A | PGC1α, mitochondrial biogenesis regulator | Links mitochondria to muscle maintenance |
| AKT1 | Kinase in IGF1-PI3K-AKT pathway | Promotes protein synthesis and inhibits atrophy |
| FOXO1 | Transcription factor promoting atrophy | Inhibited by AKT during hypertrophy |
| FBXO32 | Atrogin-1, E3 ubiquitin ligase | Degradation pathway opposed to hypertrophy |
| TRIM63 | MuRF1, E3 ubiquitin ligase | Atrophy marker, negative regulator |
How Is positive regulation of skeletal muscle hypertrophy Regulated?
Positive regulation of skeletal muscle hypertrophy is controlled by a network of anabolic and catabolic signals. mTORC1 integrates mechanical, nutritional, and hormonal inputs to promote translation and ribosome biogenesis. The IGF1-PI3K-AKT axis activates mTORC1 and inhibits FOXO transcription factors, thereby suppressing atrophy-related ubiquitin ligases such as FBXO32 and TRIM63. Satellite cell activation and myonuclear accretion are regulated by PAX7 and myogenic regulatory factors. Stress-response pathways, including HSF1-SIRT3-PGC1α, modulate mitochondrial function and proteostasis during aging. Dietary protein and exercise interact to modulate these pathways, influencing net protein balance and long-term muscle growth.
positive regulation of skeletal muscle hypertrophy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MSTN | Muscle hypertrophy and wasting disorders | MSTN knockout or knock-in models |
| FOXO1 | Cachexia and atrophy | FOXO1 knockout or point-mutation models |
| HSF1 | Sarcopenia and mitochondrial decline | HSF1 knockout or overexpression models |
| PAX7 | Satellite cell-opathies and neuromuscular disorders | PAX7 knockout or tagged knock-in models |
| MTOR | Anabolic signaling in hypertrophy and disease | MTOR knockout or point-mutation models |
Sarcopenia and Age-Related Muscle Loss
Sarcopenia is characterized by progressive loss of muscle mass and function with aging, often reflecting impaired positive regulation of skeletal muscle hypertrophy. Age-related declines in anabolic signaling, mitochondrial function, and stress responses contribute to reduced muscle protein synthesis and fiber atrophy. Network-based analyses of human skeletal muscle aging reveal coordinated changes in hypertrophic and metabolic pathways.
Cachexia and Muscle Wasting
Cachexia in cancer and chronic disease involves excessive activation of catabolic pathways and suppression of anabolic signaling, tipping the balance away from hypertrophy. Inflammatory cytokines and FOXO-driven ubiquitin ligases promote protein degradation, while mTORC1 activity is reduced. Restoring positive regulation of hypertrophy is a therapeutic goal in cachexia research.
Neuromuscular Disorders and Satellite Cell Dysfunction
Satellite cell dysfunction underlies several neuromuscular disorders, impairing the regenerative and hypertrophic capacity of muscle. Conditions termed satellite cell-opathies highlight how defects in satellite cell activation, proliferation, or differentiation compromise muscle growth and repair. Understanding positive regulators of hypertrophy in this context may inform therapeutic strategies.
From positive regulation of skeletal muscle hypertrophy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for hypertrophy? | CRISPR knockout in muscle cell lines or mouse models |
| Does a specific mutation alter anabolic signaling? | CRISPR point mutation knock-in |
| Does overexpression drive hypertrophy? | CRISPR-mediated overexpression or transgenic models |
| Where is a protein localized during hypertrophy? | Tagged knock-in (e.g., GFP) models |
| Which genes are essential for satellite cell function? | CRISPR library screening in primary myoblasts |
| How does a gene affect translation efficiency? | Ribo-seq in knockout vs wild-type cells |
How to Study the positive regulation of skeletal muscle hypertrophy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance | Identify hypertrophy-associated gene programs |
| Ribo-seq | Translation efficiency | Map mTORC1-dependent translation |
| Proteomics | Protein abundance and modifications | Quantify myofibrillar accretion |
| Phosphoproteomics | Kinase substrate phosphorylation | Monitor mTORC1 activity |
| Immunofluorescence | Fiber size and myonuclear number | Assess hypertrophy in tissue sections |
| Seahorse respirometry | Mitochondrial respiration | Evaluate metabolic adaptation |
| Stable isotope tracers | Muscle protein synthesis rates | Measure anabolic response to exercise and nutrition |
Transcriptomic and Translational Profiling
RNA-seq and Ribo-seq can quantify changes in gene expression and translation efficiency during hypertrophic stimulation. These methods help identify genes and pathways positively regulating muscle growth and reveal mTORC1-dependent translational programs.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics measures changes in myofibrillar protein content and post-translational modifications, providing direct evidence of anabolic signaling and protein accretion. Phosphoproteomics can map mTORC1 substrate phosphorylation in response to loading or nutrients.
Imaging and Morphometry
Immunofluorescence and confocal imaging of muscle fibers allow measurement of cross-sectional area, myonuclear number, and satellite cell fusion, which are key readouts of hypertrophy. Live-cell imaging can track myoblast fusion and myotube formation.
Functional and Metabolic Assays
Seahorse respirometry and mitochondrial function assays assess metabolic adaptation during hypertrophy, including SIRT3-PGC1α-dependent pathways. Muscle protein synthesis can be measured using stable isotope tracers in vivo.
How CRISPR Can Be Used to Study GO:1904206 positive regulation of skeletal muscle hypertrophy
Knockout
CRISPR knockout of candidate genes in muscle cell lines or mouse models can determine whether a gene is required for positive regulation of skeletal muscle hypertrophy. For example, knocking out MTOR or RPTOR abolishes mTORC1 signaling and impairs hypertrophy.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid substitutions to test the function of phosphorylation sites or catalytic residues in hypertrophy-related proteins. This approach helps dissect signaling mechanisms without confounding effects of complete gene loss.
Knock-in
Knock-in of reporter tags or human disease variants allows tracking of protein localization and function during hypertrophy. Tagged knock-in models are useful for imaging satellite cell dynamics and myonuclear accretion.
Overexpression
CRISPR-mediated overexpression or transgenic models can test whether increasing the level of a candidate gene is sufficient to drive hypertrophy. Overexpression of IGF1 or HSF1, for example, can enhance anabolic signaling and protect against muscle decline.
How EDITGENE Supports positive regulation of skeletal muscle hypertrophy Research
Researchers studying positive regulation of skeletal muscle hypertrophy-related genes often need to determine whether a candidate gene is causally involved in muscle growth or whether it is merely a correlative marker. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal experiments, from knockout and point mutation to knock-in, overexpression, and library screening, supported by advanced bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of skeletal muscle hypertrophy research.
Frequently Asked Questions About positive regulation of skeletal muscle hypertrophy
What is GO:1904206?
GO:1904206 is the Gene Ontology term for positive regulation of skeletal muscle hypertrophy, defined as any process that activates or increases the frequency, rate, or extent of skeletal muscle hypertrophy.
What genes are involved in positive regulation of skeletal muscle hypertrophy?
Key genes include MTOR, RPTOR, RPS6KB1, IGF1, MSTN, PAX7, MYOD1, HSF1, SIRT3, and PPARGC1A, among others.
How does mTORC1 regulate skeletal muscle hypertrophy?
mTORC1 integrates mechanical and nutritional signals to promote translation initiation and ribosome biogenesis, driving protein synthesis and muscle growth.
What is the role of satellite cells in muscle hypertrophy?
Satellite cells are muscle stem cells that activate, proliferate, and fuse with existing fibers to donate myonuclei, supporting hypertrophic growth.
How does exercise stimulate muscle hypertrophy?
Resistance exercise increases mechanical tension and muscle protein synthesis, activating anabolic signaling pathways that positively regulate hypertrophy.
What is the relationship between dietary protein and muscle hypertrophy?
Dietary protein provides amino acids that stimulate muscle protein synthesis and improve net protein balance, supporting hypertrophy when combined with exercise.
How is sarcopenia related to positive regulation of skeletal muscle hypertrophy?
Sarcopenia involves impaired anabolic signaling and mitochondrial function, reducing the positive regulation of hypertrophy and leading to muscle loss.
What research methods are used to study skeletal muscle hypertrophy?
Common methods include RNA-seq, Ribo-seq, proteomics, phosphoproteomics, immunofluorescence, and stable isotope tracer studies.
Can CRISPR be used to study muscle hypertrophy genes?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models enable causal testing of genes in hypertrophy pathways.
What is the role of HSF1 in muscle aging?
HSF1 alleviates age-associated sarcopenia and mitochondrial decline via the SIRT3-PGC1α axis, linking stress responses to muscle maintenance.
Conclusion
GO:1904206, positive regulation of skeletal muscle hypertrophy, encompasses the anabolic signaling, translational control, and cellular adaptations that drive muscle fiber growth. Understanding these processes is essential for addressing muscle wasting in aging, cachexia, and neuromuscular disorders. CRISPR-based functional genomics, combined with multi-omics and imaging, offers powerful tools to identify and validate the genes that positively regulate skeletal muscle hypertrophy.
References
- 1. Schiaffino S et al.. 2021. Molecular Mechanisms of Skeletal Muscle Hypertrophy.. J Neuromuscul Dis 8(2):169-183 PMID: 33216041
- 2. Schiaffino S et al.. 2013. Mechanisms regulating skeletal muscle growth and atrophy.. FEBS J 280(17):4294-314 PMID: 23517348
- 3. Tipton KD et al.. 2001. Exercise, protein metabolism, and muscle growth.. Int J Sport Nutr Exerc Metab 11(1):109-32 PMID: 11255140
- 4. Greyvenstein D et al.. 2026. Tension to Translation: External to Internal Processes in Muscle Hypertrophy.. Physiology (Bethesda) 41(4):0 PMID: 41324917
- 5. Carbone JW et al.. 2019. Dietary Protein and Muscle Mass: Translating Science to Application and Health Benefit.. Nutrients 11(5) PMID: 31121843
- 6. Zhang J et al.. 2026. Skeletal Muscle HSF1 Alleviates Age-Associated Sarcopenia and Mitochondrial Function Decline via SIRT3-PGC1α Axis.. Adv Sci (Weinh) 13(11):e10368 PMID: 41400028
- 7. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 8. Stokes T et al.. 2026. A network-based atlas of human skeletal muscle aging.. medRxiv PMID: 41757196
